Roar Biomedical, Inc is a pioneering company in the biotechnology and life sciences industries, focusing on the development, manufacturing, and marketing of innovative fluorescence-based methods. Since its founding in 1997, the company has been dedicated to advancing plasma analyses with proprietary activity assay kits and active protein sources. Their specialization lies in plasma cholesteryl ester transfer protein activity assays, which remain unaffected by endogenous lipoprotein concentrations.
Their product line is characterized by its cutting-edge technology and precision, offering solutions that meet the demands of the biotechnology and life sciences sectors. Roar Biomedical's dedication to innovation and scientific excellence places them at the forefront of their field, making them an attractive prospect for venture capital investment.
